BioCentury
ARTICLE | Company News

EKR, ProStrakan sales and marketing update

March 23, 2009 7:00 AM UTC

Under an exclusive, three-year, renewable deal, the partners will co-promote EKR's Gelclair povidone in the U.S. to treat pain associated with oral mucositis. EKR has North American rights to the bio...